{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:45:09Z","timestamp":1790484309943,"version":"4.1.0"},"reference-count":29,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2005,11,29]],"date-time":"2005-11-29T00:00:00Z","timestamp":1133222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[2006,1]]},"abstract":"<jats:title>Abstract.<\/jats:title><jats:p><jats:bold>Background.\u2002<\/jats:bold> Loop diuretics (LD) increase renal calcium excretion. Discrepant results on associations between LD and fracture risk have been reported.<\/jats:p><jats:p><jats:bold>Objective.\u2002<\/jats:bold> To assess the fracture risk in users of LD.<\/jats:p><jats:p><jats:bold>Design and subjects.\u2002<\/jats:bold> A population\u2010based pharmaco\u2010epidemiological case\u2013control design with fracture in year 2000 as outcome and use of LD during the previous 5\u2003years as exposure variable. We used nationwide computerized registers to assess individual use of LD and related these data to individual fracture data and information on potential confounders. We compared 64\u2003699 cases aged 40\u2003years or more who sustained a fracture during year 2000 with 194\u2003111 age\u2010 and gender\u2010matched controls.<\/jats:p><jats:p><jats:bold>Results.\u2002<\/jats:bold> A total of 44\u2003001 subjects used LD. Ever use of LD was associated with a crude 51% (OR 1.51; 95% CI 1.48\u20131.55) increased risk of any fracture and a 72% (OR 1.72; 95% CI 1.64\u20131.81) increased risk of hip fracture. The risk estimates were reduced after confounder adjustment, i.e. adjusted risk of any fracture was increased by 4% (OR 1.04; 95% CI 1.01\u20131.07) and risk of hip fracture by 16% (OR 1.16; 95% CI 1.10\u20131.23). In current users, a tendency towards a decreased fracture risk with increased dose was observed, whereas in former users risk of fracture increased with increased dose. Use of furosemide was associated with higher risk estimates than use of bumetanide.<\/jats:p><jats:p><jats:bold>Conclusion.\u2002<\/jats:bold> Treatment with LD affects fracture risk. Special attention should be paid to patients in whom treatment with LD is initiated or stopped, as they may be at an increased risk of fracture.<\/jats:p>","DOI":"10.1111\/j.1365-2796.2005.01585.x","type":"journal-article","created":{"date-parts":[[2005,11,29]],"date-time":"2005-11-29T16:34:52Z","timestamp":1133282092000},"page":"117-124","source":"Crossref","is-referenced-by-count":71,"title":["Fracture risk in patients treated with loop diuretics"],"prefix":"10.1111","volume":"259","author":[{"given":"L.","family":"REJNMARK","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"VESTERGAARD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"MOSEKILDE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,11,29]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1159\/000183290"},{"key":"e_1_2_8_3_2","first-page":"8","article-title":"Furosemide therapy and intact parathyroid hormone plasma concentrations in chronic renal insufficiency","volume":"7","author":"Reichel H","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107156"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2003.01103.x"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2004.01434.x"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650080604"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-1-1"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.292.6524.861"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1993.tb121839.x"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.287.5462.2398"},{"key":"e_1_2_8_12_2","first-page":"263","article-title":"The Danish National Hospital Register. A valuable source of data for modern health sciences","volume":"46","author":"Andersen TF","year":"1999","journal-title":"Dan Med Bull"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwf007"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a116396"},{"key":"e_1_2_8_15_2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3233\/JRS-1997-10309","article-title":"The pharmacoepidemiologic prescription database of North Jutland \u2013 a valid tool in pharmacoepidemiological research","volume":"10","author":"Nielsen GL","year":"1997","journal-title":"Int J Risk Safety Med"},{"key":"e_1_2_8_16_2","first-page":"55","volume-title":"Drug Utilization Studies: Methods and Uses","author":"Capella D.","year":"1993"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(02)00585-1"},{"key":"e_1_2_8_19_2","volume-title":"Theoretical Epidemiology: Principles of Occurrence Research in Medicine","author":"Miettinen OS.","year":"1985"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00004174"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1989.tb00793.x"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1989.tb00792.x"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2001.00883.x"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199614020-00005"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/20.6.455"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.6.2201"},{"key":"e_1_2_8_27_2","first-page":"F403","article-title":"Uncoupling of proximal sodium bicarbonate from sodium phosphate transport by bumetanide","volume":"235","author":"Puschett JB","year":"1978","journal-title":"Am J Physiol"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00580.2002"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(01)00601-9"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009760"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2796.2005.01585.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2796.2005.01585.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T20:37:11Z","timestamp":1697143031000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2796.2005.01585.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,29]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["10.1111\/j.1365-2796.2005.01585.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2796.2005.01585.x","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,29]]}}}